The effects of the Prosteks (rectal suppositories with Prostatilen) in patients with prostate pain syndrome
Keywords:prostate pain syndrome, the symptoms of sexual function, libido, erection, ejaculation, orgasm, Prostatilen
The objective: to evaluate the impact of Prosteks on Domain NIH CPSI (pain discomfort) and IIEF in patients with prostate pain syn drome (PBS).
Patients and methods. The sample consisted of 30 patients with an average age of PBS 37 years (min – 25, max – 51) in which the average duration of complaints was 10 months, ranging from 6 to 23. The criteria include: persistent or recurrent episodic pain con nects patients with prostate cancer, aggravated by its palpation; pain in the prostate can not be explained by any infectious agents or local pathological process. Exclusion criteria acute and chronic infectious and inflammatory diseases of the urogenital tract. Surveys during screening, microscopic examination of urethral material midstream urine and prostatic secretions to identify the inflammatory response. To identify C.trachomatis, M.genitalium, U.urealiticum, N.gonorrhoeae, T. vaginalis, G.vaginalis urethral material was investigated by PCR. To eliminate urinary tract infections culture research conducted midstream morning urine. Also before the start of therapy and after its termination patient survey was conducted using questionnaires NIH CPSI and IIEF Daily treatment: 1 suppository of Prosteks into the anus at night for 60 days.
Results. The 2 month course of therapy with Prosteks not affect the location of pain, but was significantly and clinically signifi cantly reduced the probability of their occurrence and intensity of the perineum, vagina and over during / after ejaculation. Options painful phenomena in areas such as the head of the penis, testicles and urination influenced Prosteksa not significantly changed. In addition, after treatment Prosteksom we reported clinically mean ingful and statistically significant changes in all domains of the scale IIEF. In particular, the median value of domains that charac terize an erection, orgasm / ejaculation, libido, satisfaction with sexual intercourse and sexual life as a whole increased by 6, 2, 2, 3 and 3 points
Conclusion. 2 month course of the drug Prosteks (1 suppository into the anus at night) was significantly and clinically significantly reduces the likelihood and intensity of pain in the perineum, vagina and over during / after ejaculation. Using PBS patients with rectal suppositories Prosteks within 2 months of clinically meaningful and statistically significant increases IIEF total score scale, characterizing erectile function, ejaculation / orgasm, satisfaction with sexual intercourse and sexu al life in general.
Given the clinical effects Prosteksa, it can be recommended for the management of patients with PBS, combined with sexual disorders
Stephens Shields AJ, Clemens JQ, Jemielita T, Farrar J, Sutcliffe S, Hou X, Landis JR. Symptom variability and early symptom regression in the MAPP study: a prospective study of urological chronic pelvic pain syndrome //J Urol. 2016 Nov;196(5):1450–1455.
Breser M.L., Motrich R.D., Sanchez L.R., Rivero V.E. Chronic pelvic pain development and prostate inflammation in strains of mice with different susceptibility to experimental autoimmune prostatitis //Prostate. 2017 Jan;77(1):94–104.
Wong L., Done J.D., Schaeffer A.J., Thumbikat P. Experimental autoimmune prostatitis induces microglial activation in the spinal cord. //Prostate. 2015 Jan;75(1):50–9.
Savateeva Liubimova TN, Sivak KV, Malinin VV. Effect of prostatilen AC suppositories on course of experimental prostatitis // Urologiia. 2012 Jul Aug;(4):50–54.
Gorpynchenko II, Iakovlev GM, Boiko NI, Khavinson VKh. The treatment with the polypeptide preparation «Prostatilen» of patients with prostatitis complicated by a sexual functional disorder // Vrach Delo. 1991 Feb; (2): 48–51.
Vozianov A.F., Gorpynchenko I.I., Boiko N.I., Drannik GN, Khavinson VKh The use of prostatilen in treating patients with prostatic diseases // Urol Nefrol (Mosk). 1991 Nov Dec;(6):43–6.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF) a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 Jun; 49(6):822–30.
Copyright (c) 2020 І. І. Горпинченко, А. М. Ситенко
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The journal does not require authors of original (primary) research papers to assign the copyright of their published contributions. Authors grant the journal an non-exclusive licence CC BY 4.0 (Creative Commons Attribution 4.0 International License) to using and the first publication of the original in this journal. Copyright of the manuscripts is retained by the authors, after publication authors retain rights to reuse their papers in their future printed work without first requiring permission from the publisher of the journal and share their own published articles.
The journal supports the self-archiving process. Prior to publication in the journal, authors may post a copy of their manuscript in preparation or submitted to the journal in recognized non-commercial preprint servers, public websites. Authors also are encouraged to archive their final author version of the manuscript in their institution's repositories and, if they wish, on their personal websites. Authors should cite the publication reference and DOI number on the first page of any deposited version, and provide a link from it to the URL of the published article on the journal's website.
To facilitate self-archiving of original research papers and help authors fulfil funder and institutional mandates, the journal deposits manuscripts in National Library of Ukraine by V.I. Vernadsky, Scientific periodicals of Ukraine database and different international scintificd database on behalf of authors who opt-in to this free service during submission. The journal provides depositing of articles on official website of the publisher. The full text access to published papers is free.